PANTANO, FRANCESCO

PANTANO, FRANCESCO  

Facoltà Dipartimentale di Medicina e Chirurgia  

Mostra records
Risultati 1 - 20 di 152 (tempo di esecuzione: 0.046 secondi).
Titolo Data di pubblicazione Autore(i) File
'All action no talk': the role of HER2/neu in adjuvant therapy choice for gastric cancer 1-gen-2013 Santini, D; Vincenzi, B; Pantano, F; Schiavon, G; Tonini, G
A new bioinformatic pipeline allows the design of small, targeted gene panels for efficient TMB estimation 1-gen-2019 Manca, P; Mallona, I; Santini, D; Tonini, G; Rolfo, Cd; Robinson, Md; Pantano, F
A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins 1-gen-2018 Palermo, A; Capoluongo, E; Del Toro, R; Manfrini, S; Pozzilli, P; Maggi, D; Defeudis, G; Pantano, F; Coppola, R; Di Matteo, F; Raffaelli, M; Concolino, P; Falchetti, A
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 1-gen-2018 Croset, Martine; Pantano, Francesco; Kan, Casina; Bonnelye, Edith; Descotes, Francoise; Alix-Panabières, Catherine; Lecellier, Charles; Bachelier, Richard; Allioli, Nathalie; Hong, Saw See; Bartkowiak, Kai; Pantel, Klaus; Clézardin, Philippe
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 1-gen-2013 Pantano, F; Croset, M; Driouch, K; Santini, D; Tonini, G; Clézardin, P
Alkaline phosphatase (alp) levels in multiple myeloma and solid cancers with bone lesions: Is there any difference? 1-gen-2021 Annibali, O.; Petrucci, M. T.; Santini, D.; Bongarzoni, V.; Russano, M.; Pisani, F.; Venditti, O.; Pantano, F.; Rago, A.; Siniscalchi, A.; Cerchiara, E.; Franceschini, L.; De Rosa, L.; Mariani, M.; Andriani, S.; Cudillo, L.; Garcia, M.; Cantonetti, M.; Mohamed, S.; Anaclerico, B.; Caravita, T.; Stocchi, F.; Cimino, G.; Gumenyuk, S.; Vozella, F.; Avvisati, G.
Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells. 1-gen-2015 Grimaldi, A; Santini, D; Zappavigna, S; Lombardi, A; Misso, G; Boccellino, M; Desiderio, V; Vitiello, Pp; Di Lorenzo, G; Zoccoli, A; Pantano, F; Caraglia, M.
Anterior and posterior vaginal myomectomy: A new surgical technique 1-gen-2006 Carminati, R.; Ragusa, A.; Giannice, R.; Pantano, F.
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 1-gen-2020 Dell'Aquila, E; Zeppola, T; Stellato, M; Pantano, F; Scartozzi, M; Madaudo, C; Pietrantonio, F; Cremolini, C; Aprile, G; Vincenzi, B; Moretto, R; Puzzoni, M; Garattini, Sk; Lobefaro, R; Tonini, G; Santini, D
Antitumor effect of cabozantinib in bone metastatic models of renal cell carcinoma 1-gen-2021 Iuliani, M.; Simonetti, S.; Pantano, F.; Ribelli, G.; Di Martino, A.; Denaro, V.; Vincenzi, B.; Russo, A.; Tonini, G.; Santini, D.
Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment 1-gen-2015 Iuliani, Michele; Pantano, Francesco; Buttigliero, Consuelo; Fioramonti, Marco; Bertaglia, Valentina; Vincenzi, B; Zoccoli, Alice; Ribelli, Giulia; Tucci, Marcello; Vignani, Francesca; Berruti, Alfredo; Scagliotti Giorgio, Vittorio; Tonini, Giuseppe; Santini, Daniele
Biological effects of cabozantinib on bone microenvironment 1-gen-2016 Pantano, Francesco; Fioramonti, Marco; Iuliani, Michele; Ribelli, Giulia; Vincenzi, Bruno; Tonini, Giuseppe; Santini, Daniele
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 1-gen-2016 Iuliani, M.; Fioramonti, M.; Fausti, V.; Ribelli, G.; Pantano, F.; Santini, D.; Tonini, G.; Vincenzi, B.
Biological Effects of Cyclin-Dependent Kinase Inhibitors Ribociclib, Palbociclib and Abemaciclib on Breast Cancer Bone Microenvironment 1-gen-2022 Iuliani, M.; Simonetti, S.; Ribelli, G.; Napolitano, A.; Longo, U. G.; Vincenzi, B.; Orsaria, P.; Denaro, V.; Tonini, G.; Santini, D.; Pantano, F.
Bisphosphonates as anticancer agents in early breast cancer: preclinical and clinical evidence 1-gen-2015 Santini, Daniele; Stumbo, Luciano; Spoto, Chiara; D'Onofrio, Loretta; Pantano, Francesco; Iuliani, Michele; Fioramonti, Marco; Zoccoli, Alice; Ribelli, Giulia; Virzi, Vladimir; Vincenzi, B; Tonini, Giuseppe
Body mass index and impaired fasting blood glucose as predictive factor of time to progression (TTP) in cetuximab-based colorectal cancer treatment 1-gen-2013 Pantano, Francesco; Guida Francesco, Maria; Vivaldi, Caterina; Vincenzi, Bruno; Grande, Enrique; Garrote Mercedes, Rodriguez; Caraglia, Michele; Silvestris, Nicola; Vasile, Enrico; Masi, Gianluca; Falcone, Alfredo; Tonini, G; Santini, Daniele
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 1-gen-2012 Guida, F. M.; Pantano, F.; Vasile, E.; Garrote, M. Rodriguez; Grande, E.; Silvestris, N.; Vincenzi, B.; Santini, D.; Falcone, A.; Tonini, G.
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 1-gen-2023 Ippolito, Edy; Silipigni, Sonia; Pantano, Francesco; Matteucci, Paolo; Carrafiello, Sofia; Marrocco, Maristella; Alaimo, Rita; Palumbo, Vincenzo; Fiore, Michele; Orsaria, Paolo; D'Angelillo, Rolando Maria; Altomare, Vittorio; Tonini, Giuseppe; Ramella, Sara
Bone Health in Cancer Patients 1-gen-2018 Santini, D; Ribelli, G; Simonetti, S; Iuliani, M; Pantano, F; Tonini, G
Bone metastases in biliary cancers: A multicenter retrospective survey 1-gen-2018 Santini, D; Brandi, G; Aprile, G; Russano, M; Cereda, S; Leone, F; Lonardi, S; Fornaro, L; Scartozzi, M; Silvestris, N; Barni, S; Pantano, F; Vincenzi, B; Palloni, A; Frega, G; Casagrande, M; Ferrari, L; Dadduzio, V; Intini, R; Filippi, R; Vasile, E; Vivaldi, C; Faloppi, L; Brunetti, O; Reni, M; Aglietta, M; Tonini, G